Clinical trial
Canadian Treat and Extend Analysis Trial With Ranibizumab
NCT02103738 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Treat and Extend Analysis Trial With Ranibizumab
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 8, 2013
- Completion date
- July 31, 2019
- Enrollment
- 505 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
wetamd